Essential tremor (ET) is defined as uncontrollable shaking of the hands, arms, and sometimes other parts of the body. It is the most common of all movement disorders. In almost half of the cases, ET is inherited in an autosomal dominant manner. The degree of severity of symptoms varies amongst patients. It mostly affects the hands and arms, but may also involve the legs, trunk, head, voice, and chin.

This report provides the current prevalent population for Essential Tremor across 24 Major Markets (USA, France, Germany, Italy, Spain, UK, Japan, Canada, Netherlands, Belgium, Switzerland, Austria, Denmark, Poland, Russia, Brazil, Mexico, Argentina, Turkey, Ireland, Australia, China, South Korea, India) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, Essential Tremor patients grouped by location, type and treatment status have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main locations and types of Essential Tremor include:

  • Kinetic Tremor
  • Postural Tremor
  • Resting Tremor
  • Lower limb Tremor
  • Upper limb Tremor
  • Voice Tremor

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world-class sources that deliver the most up-to-date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Ability to quantify patient populations in global Essential Tremor market to target the development of future products, pricing strategies and launch plans.
  • Further insight into the prevalence of the subdivided types of Essential Tremor and identification of patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Identification of Essential Tremor patient sub-populations that require treatment.
  • Better understanding of the specific markets that have the largest number of Essential Tremor patients.